 | Up a level |
Joussen, Antonia M; Wolf, Sebastian; Kaiser, Peter K; Boyer, David; Schmelter, Thomas; Sandbrink, Rupert; Zeitz, Oliver; Deeg, Gesa; Richter, Annett; Zimmermann, Torsten; Hoechel, Joachim; Buetehorn, Ulf; Schmitt, Walter; Stemper, Brigitte; Boettger, Michael K (2019). The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial. British journal of clinical pharmacology, 85(2), pp. 347-355. Wiley-Blackwell 10.1111/bcp.13794
